Tradestie Institutional Equity Comparison Engine

NDAQ vs CME โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NDAQ Overall Edge

NDAQ Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nasdaq, Inc. Common Stock (NDAQ) driven by superior Valuation, Momentum & Technical, Options & Structure while CME counters with relative strength in Growth & Margin. Fundamentally, NDAQ trades at 22.9x Forward P/E with 49.0% operating margin (+12.6% YoY revenue) versus CME at 24.1x Forward P/E and 66.2% operating margin (+13.0% YoY). In options structure, NDAQ sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against CME sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NDAQ
NDAQ 22.9x vs CME 24.1x Fwd P/E
Growth & Margin Winner CME
Op Margin 49.0% vs 66.2% ยท YoY +12.6% vs +13.0%
Momentum & Technical Winner NDAQ
1Y +20.9% vs +9.4% ยท 52W Pos 82% vs 84%
Options & Structure Winner NDAQ
CONSOLIDATION (10th %ile IV) vs CONSOLIDATION (10th %ile IV)
NDAQ NASDAQ
Nasdaq, Inc. Common Stock
Security & Commodity Brokers, Dealers, Exchanges & Services
$105.32
-2.95% 1D
Market Cap $60.2B
1M Return +13.0%
1Y Return +20.95%
Forward P/E 22.9x
Unified AI Score
45.2 / 100 HOLD
Tech 32.0 Fund 47.0 Flow 58.0 Mom 60.0
CME NASDAQ
CME Group Inc.
Security & Commodity Brokers, Dealers, Exchanges & Services
$311.77
-2.38% 1D
Market Cap $113.8B
1M Return +6.21%
1Y Return +9.38%
Forward P/E 24.1x
Unified AI Score
38.6 / 100 SELL
Tech 19.0 Fund 29.0 Flow 55.0 Mom 11.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NDAQ +20.95% CME +9.38% Spread: +11.57 pp (NDAQ Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NDAQ Revenue CME Revenue NDAQ Op. Margin CME Op. Margin Margin Edge
FY2018 $4.28B $4.31B 24.0% 60.5% CME
FY2019 $4.26B $4.87B 23.9% 53.2% CME
FY2020 $5.62B $4.88B 21.9% 54.0% CME
FY2021 $5.89B $4.69B 24.5% 56.4% CME
FY2022 $6.23B $5.02B 25.1% 60.1% CME
FY2023 $6.06B $5.58B 26.0% 61.6% CME
FY2024 $7.40B $6.13B 24.3% 64.1% CME
FY2025 $8.26B $6.52B 28.2% 64.9% CME

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NDAQ (3) vs CME (7)
Institutional Metric NDAQ CME Criterion Row Winner
Market Capitalization Scale $60.2B $113.8B Larger Scale CME
Trailing P/E Ratio Valuation 29.6x 26.1x Lower Multiple CME
Forward P/E Ratio Valuation 22.9x 24.1x Lower Multiple NDAQ
Revenue Growth (YoY) Growth +12.6% +13.0% Higher Growth CME
Operating Margin (TTM) Profitability 49.0% 66.2% Higher Margin CME
Net Profit Margin Profitability 36.1% 63.5% Higher Margin CME
Return on Equity (ROE) Capital Efficiency 17.3% 16.1% Higher ROE NDAQ
52-Week Range Position Momentum 82% ($77โ€“$111) 84% ($218โ€“$329) Stronger Trend CME
Beta / 30D Volatility Risk Regime 0.43ฮฒ ยท 32% Vol -0.32ฮฒ ยท 26% Vol Lower Realized Risk CME
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite NDAQ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NDAQ vs CME Buy Guide
NDAQ CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live NDAQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CME CONSOLIDATION
54d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live CME Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NDAQ nor CME registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.